RIGEL PHARMACEUTICALS INC Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • Rigel Pharmaceuticals Inc Interest Expense for the quarter ending September 30, 2024 was $2.06M, a 8.48% increase year-over-year.
  • Rigel Pharmaceuticals Inc Interest Expense for the twelve months ending September 30, 2024 was $7.87M, a 29.6% increase year-over-year.
  • Rigel Pharmaceuticals Inc annual Interest Expense for 2023 was $6.87M, a 85.4% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Interest Expense for 2022 was $3.71M, a 23.7% decline from 2021.
  • Rigel Pharmaceuticals Inc annual Interest Expense for 2021 was $4.86M, a 259% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.87M +$3.17M +85.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $3.71M -$1.15M -23.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $4.86M +$3.51M +259% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $1.35M +$1.02M +304% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 $335K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2011 $25K -$66K -72.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 $91K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.